PetMed Express Income Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	186.96	226.97	274.1	247.57	272.28	303.58
Revenue Growth (YoY)	-20.69%	-17.19%	10.71%	-9.08%	-10.31%	6.85%
Cost of Revenue	135.49	157.84	189.33	171.07	195.34	219.27
Gross Profit	51.47	69.14	84.77	76.5	76.94	84.32
Selling, General & Admin	80.28	71.57	85.25	65.7	49.91	51.36
Other Operating Expenses	-	-1.18	-1.09	0.34	-	-
Operating Expenses	89.31	77.43	91.22	69.59	52.65	53.79
Operating Income	-37.84	-8.29	-6.45	6.92	24.29	30.53
Interest Expense	-0.82	-	-	-	-1.13	-0.9
Interest & Investment Income	-	0.19	0.51	0.45	-	-
Other Non Operating Income (Expenses)	0.65	0.76	1.38	0.94	1.03	1.32
EBT Excluding Unusual Items	-38.02	-7.35	-4.56	8.31	24.19	30.95
Merger & Restructuring Charges	-	-	-1.2	-0.5	-	-
Asset Writedown	-1.76	-1.2	-	-	-	-
Other Unusual Items	7.3	7.96	-0.51	-0.36	-	-
Pretax Income	-59.18	-0.59	-6.27	7.45	24.19	30.95
Income Tax Expense	5.69	5.68	1.19	2.31	5.47	7.03
Net Income	-64.87	-6.27	-7.46	5.14	18.72	23.92
Net Income to Common	-64.87	-6.27	-7.46	5.14	18.72	23.92
Net Income Growth	-	-	-	-72.54%	-21.75%	-7.47%
Shares Outstanding (Basic)	21	21	20	20	20	20
Shares Outstanding (Diluted)	21	21	20	20	20	20
Shares Change (YoY)	-0.13%	0.98%	0.28%	-0.09%	1.19%	0.32%
EPS (Basic)	-3.12	-0.30	-0.37	0.25	0.93	1.19
EPS (Diluted)	-3.12	-0.30	-0.37	0.25	0.92	1.19
EPS Growth	-	-	-	-72.83%	-22.69%	-7.75%
Free Cash Flow	-22.92	-0.4	-0.19	22.54	16.75	37.64
Free Cash Flow Per Share	-1.10	-0.02	-0.01	1.11	0.82	1.87
Dividend Per Share	-	-	0.600	1.200	1.200	1.120
Dividend Growth	-	-	-50.00%	-	7.14%	3.70%
Gross Margin	27.53%	30.46%	30.93%	30.90%	28.26%	27.77%
Operating Margin	-20.24%	-3.65%	-2.35%	2.79%	8.92%	10.06%
Profit Margin	-34.70%	-2.76%	-2.72%	2.08%	6.87%	7.88%
Free Cash Flow Margin	-12.26%	-0.17%	-0.07%	9.11%	6.15%	12.40%
EBITDA	-28.81	-1.25	-0.39	10.46	27.03	32.96
EBITDA Margin	-15.41%	-0.55%	-0.14%	4.23%	9.93%	10.86%
D&A For EBITDA	9.03	7.04	6.06	3.55	2.74	2.43
EBIT	-37.84	-8.29	-6.45	6.92	24.29	30.53
EBIT Margin	-20.24%	-3.65%	-2.35%	2.79%	8.92%	10.06%
Effective Tax Rate	-	-	-	30.96%	22.61%	22.72%
Advertising Expenses	-	23.78	30.63	25.19	18.8	21.64

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q